Nafpenzal Dry Cow

Land: Storbritannia

Språk: engelsk

Kilde: VMD (Veterinary Medicines Directorate)

Aktiv ingrediens:

Dihydrostreptomycin, Nafcillin, Procaine Benzylpenicillin

Tilgjengelig fra:

Intervet International BV

ATC-kode:

QJ51RC23

INN (International Name):

Dihydrostreptomycin, Nafcillin, Procaine Benzylpenicillin

Legemiddelform:

Intramammary suspension

Resept typen:

POM-V - Prescription Only Medicine – Veterinarian

Terapeutisk gruppe:

Cattle

Terapeutisk område:

Antimicrobial intramammary

Autorisasjon status:

Authorized

Autorisasjon dato:

1976-08-26

Preparatomtale

AN: 00665/2015
Revised: October 2015
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Nafpenzal Dry Cow
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 3 g syringe contains:
ACTIVE SUBSTANCES:
Procaine benzylpenicillin
300 mg
Dihydrostreptomycin(as the sulphate)
100 mg
Nafcillin (as the sodium salt)
100 mg
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Intramammary suspension.
White, to off-white suspension.
4.
CLINICAL PARTICULARS
4.1.
TARGET SPECIES
Cattle (dry cows)
4.2.
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For dry cow therapy (treatment of existing subclinical infections and
the prevention of
new infections which might occur during the dry period, caused by
bacteria sensitive
to penicillin, streptomycin or nafcillin).
4.3
CONTRAINDICATIONS
Do not use in case of hypersensitivity to penicillin, nafcillin or
dihydro-streptomycin,
or to any of the excipients.
Do not use in lactating animals.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
AN: 00665/2015
Revised: October 2015
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Not applicable.
Special precautions to be taken by the person administering the
veterinary medicinal
product to animals
_To the user:_
Penicillin and cephalosporins may cause hypersensitivity (allergy)
following injection,
inhalation, ingestion or skin contact.
Hypersensitivity to penicillin may lead to cross reactions to
cephalosporins and _vice _
_versa_.
Allergic reactions to these substances are occasionally serious.
1. Do not handle this product if you know you are sensitised or if you
have been
advised not to work with such preparations.
2. Handle this product with great care to avoid exposure, taking all
recommended
precautions.
3. If you develop symptoms following exposure, such as a skin rash,
you should
seek medical advice and show the doctor this warning. Swelling of the
face, lips or
eyes or difficulty with breathing are more serious symptoms and
require urgent
medical attention.
4. Wash h